학술논문
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Document Type
Artikel
Author
Bergman, P; Blennow, O; Hansson, L; Mielke, S; Nowak, P; Chen, PR; Soderdahl, G; Osterborg, A; Smith, CIE; Wullimann, D; Vesterbacka, J; Lindgren, G; Blixt, L; Friman, G; Wahren-Borgstrom, E; Nordlander, A; Gomez, AC; Akber, M; Valentini, D; Norlin, AC; Thalme, A; Bogdanovic, G; Muschiol, S; Nilsson, P; Hober, S; Lore, K; Chen, MS; Buggert, M; Ljunggren, HG; Ljungman, P; Aleman, S
Source
EBioMedicine. 74:103705
Subject
Language
English
English
English
ISSN
2352-3964